Takeda and Roivant launch Myovant Sciences Ltd
Takeda and Roivant Sciences have launched Myovant Sciences Ltd., a biopharmaceutical company focused on delivering innovative women’s health and prostate cancer therapeutics.
Click on this link for more information.
